MEG3 and carcinoma: To validate the above-cited findings, we performed the bisulfite-PCR analysis of the CGIs situated in MEG3-DMR in the normal thyroid-derived cell line NThy-ORI and the BRAF-mutated BCPAP, which resemble aggressive features observed in patients with poorly differentiated carcinomas.